Metastatic Cancer | sciencenewsnet.in

Breaking News

Actions Chinese Family Caregivers Take Potentially Preventing Stroke Survivors’ Rehospitalization

Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots

Engagement Strategies for Safe Patient Handling in the Rehab Setting

Machine learning predicts antibiotic resistance spread

Study: Massachusetts Gun-Control Legislation Has Had No Effect on Violent Crime

Climate change lowers nutrition, increases toxicity at base of food web

Climate Champion Professor Mihri Ozkan discusses recent advances in the development and application of CO2 capture materials and also addresses the main challenges that need to be overcome in order to bring these material technologies to the market.

Experiments confirm a quantum material’s unique response to circularly polarized laser light

More than half of Utah’s households unable to afford median home price, report shows

Nurses think about suicide more than other workers

22 Oct, 2021

Prominent Scientist Julio Aguirre-Ghiso, Ph.D., To Lead New Cancer Dormancy and Tumor Microenvironment Institute at Albert Einstein Cancer Center

June 16, 2021 sarah JonasAnnouncement

Albert Einstein Cancer Center (AECC), Albert Einstein College of Medicine, and Montefiore Health System today announced that leading cancer biologist Julio Aguirre-Ghiso, Ph.D., has been named founding director of the Cancer Dormancy and Tumor Microenvironment Institute (CDTMI), director of the Gruss-Lipper Biophotonics Center, and co-leader of the AECC Tumor Microenvironment and Metastasis Program. He will also be an endowed professor of cell biology at Einstein. He will assume his new roles on October 1, 2021.

UPMC Hillman Among First to Offer Biology-Guided Radiotherapy

June 16, 2021 sarah JonasFeature

RefleXion™X1 is world’s first biology-guided radiotherapy (BgRT) machine that’s expected to improve treatment and expand options for patients with metastatic disease by incorporating PET, CT & radiation in one device.